Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711

K-Number: K851812 · 1985-06-05

ApplicantVictoreen, Inc.
Decision Date1985-06-05
Product CodeIXF
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711 is the device name listed in this FDA 510(k) record. The listed applicant is Victoreen, Inc.. It received FDA 510(k) clearance on 1985-06-05 under 510(k) number K851812. The device is classified under product code IXF. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711?

DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711 is a medical device that received FDA 510(k) clearance on 1985-06-05. The listed applicant is Victoreen, Inc.. The 510(k) number is K851812.

When did DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711 receive FDA 510(k) clearance?

DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711 received FDA 510(k) clearance on 1985-06-05, under 510(k) number K851812.

Who is the listed applicant for DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711?

The FDA 510(k) record lists Victoreen, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711?

The FDA product code for DIGITAL SUBTRACTION ANTIOGRAPHY PHANTOM 76-700/711 is IXF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Victoreen, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K982937MODEL 580-006 RADIATION THERAPY IONIZATION CHAMBERK974112VACUDAP, MODEL 2000, 2001K973960MODEL 37-185K964952VERIDOSE V (FIVE), MODEL NUMBER 37-705K964785VERIDOSE DIODESK971382PRONE BREAST POSITIONING BOARD, MODEL #37-018

View all 40 devices →

Related Devices (Code: IXF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K865100TISSUE-EQUIVALENT BREAST SIMULATORComputerized Imaging Reference Systems, Inc.K834482TISSUE MIMICKING ULTRASOUND PHANTOMSRadiation Measurements, Inc.K834481DOPPLER PHANTOM FLOW CONTROL SYSRadiation Measurements, Inc.K8102541.5` FOCAL SPOT RESOLUTION PATTERNMachlett Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑